Ledger.Open graph →
SEC Form D · filed June 8, 2022

U1 Bio, Inc

Offering
$10.7M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

David Nelles · San Francisco, CAExec · DirectorKonstantinos Charizanis · San Francisco, CAExec · DirectorCharles Shao · New York, NYExec · DirectorEnda K. Fahy · Grand Duchy of Luxembourg, LuxembourgExec · DirectorSharam Seyedin-Noor · Belvedere Tiburon, CADirectorWilliam J. Geary · Boston, MAExec · DirectorRobert Welge, Iii · Winnetka, ILExec · DirectorSharam Seyedin-Noor · Belvedere Tiburon, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗